RASSF10: A Potential Drug Target and Biomarker for Various Diseases

Target Name: RASSF10

NCBI ID: G644943

RASSF10

Other Name(s): Ras association domain family member 10 | Ras association (RalGDS/AF-6) domain family (N-terminal) member 10 | Ras association domain family protein 10 (RASSF10) | Ras association domain-containing protein 10 | Peptidylglycine alpha-amidating monooxygenase COOH-terminal interactor-like | RASFA_HUMAN

RASSF10: A Potential Drug Target and Biomarker for Various Diseases

Ras association domain family member 10 (RASSF10) is a gene that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. In this article, we will discuss the research on RASSF10 and its potential as a drug target and biomarker.

Background

Ras (Ras-associated protein of 26kDa) is a G protein-coupled receptor that plays a crucial role in cell signaling pathways. It is involved in various signaling pathways, including cell proliferation, differentiation, and survival. RASSF10 is a gene that is closely related to the RAS signaling pathway and has been identified as a potential drug target and biomarker.

Drugs that target RASSF10 have the potential to treat various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, inhibitors of the RASSF10 gene have been shown to have anti-tumor and anti-inflammatory effects in various cancer models. Additionally, RASSF10 has been shown to be involved in neurodegenerative diseases, including Alzheimer's and Parkinson's diseases, and may be a potential biomarker for these conditions.

Expression and function of RASSF10

RASSF10 is a gene that is expressed in various tissues and cells, including neurons, glial cells, and immune cells. It is a member of the RAS signaling pathway and is involved in the regulation of cell signaling pathways, including cell proliferation, differentiation, and survival.

RASSF10 is involved in several signaling pathways, including the cell proliferation pathway. It has been shown to play a role in the regulation of cell proliferation by promoting the growth of neurons and glial cells, and by inhibiting the growth of cancer cells. Additionally, RASSF10 has been shown to play a role in the regulation of cell differentiation by promoting the formation of neural stem cells and by inhibiting the formation of other cell types.

RASSF10 is also involved in the regulation of cell survival. It has been shown to play a role in the regulation of cell survival by promoting the production of factors that promote cell survival, such as Ets, and by inhibiting the production of factors that promote cell death, such as p53. Additionally, RASSF10 has been shown to play a role in the regulation of apoptosis, which is a natural process that helps cells remove damaged or unnecessary proteins and organelles.

Drug targeting RASSF10

Inhibitors of the RASSF10 gene have been shown to have various therapeutic effects in cancer, neurodegenerative diseases, and autoimmune disorders. For example, inhibitors of the RASSF10 gene have been shown to have anti-tumor and anti-inflammatory effects in various cancer models, including colon cancer, lung cancer, and neuroblastoma.

In addition to inhibitors, small molecules that can interact with RASSF10 have also been shown to be potential drug targets. For example, inhibitors of the RASSF10 gene have been shown to interact with several protein substrates, including Rabp12, which is a protein that plays a role in regulating the activity of RASSF10. Additionally, inhibitors of the RASSF10 gene have been shown to interact with several intracellular signaling pathways, including the PI3K/Akt signaling pathway.

Biomarker potential of RASSF10

RASSF10 has also been identified as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, RASSF10 has been shown to be involved in the regulation of cancer cell growth and has been used as a potential biomarker for cancer. Additionally, RASSF10 has

Protein Name: Ras Association Domain Family Member 10

Functions: Plays an important role in regulating embryonic neurogenesis

The "RASSF10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RASSF10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets